ロード中...
Trastuzumab cardiotoxicity: from clinical trials to experimental studies
Epidermal growth factor receptor‐2 (HER‐2) is overexpressed in 20 to 25% of human breast cancers, which is associated with aggressive tumour growth and poor prognosis. Trastuzumab (Herceptin®) is a humanized monoclonal antibody directed against HER‐2, the first highly selective form of therapy targe...
保存先:
| 出版年: | Br J Pharmacol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5647179/ https://ncbi.nlm.nih.gov/pubmed/27714776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13643 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|